Showing results (621-630 of 3,789) with videos related to

Sort By:
Pageof 379
Oncoimmunology|January 18, 2021
Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapySandra Martinez-Morilla, Jon Zugazagoitia, Pok Fai Wong, et al.
Oncoimmunology|January 18, 2021
Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS studyFabrice Barlesi, Adrien Dixmier, Didier Debieuvre, et al.
Oncoimmunology|January 18, 2021
RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic"Bryan Oronsky, Corey A Carter, Scott Caroen, et al.
Oncoimmunology|January 18, 2021
Immunotherapy with NK cells: recent developments in gene modification open up new avenuesLisa Marie Reindl, Nawid Albinger, Tobias Bexte, et al.
Oncoimmunology|January 18, 2021
Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancerSarah Schmidt, Weldy V Bonilla, Andrea Reiter, et al.
Oncoimmunology|January 18, 2021
Pirfenidone facilitates immune infiltration and enhances the antitumor efficacy of PD-L1 blockade in miceWan Qin, Jun Zou, Yongbiao Huang, et al.
Oncoimmunology|February 4, 2021
Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinomaTaigo Kato, Kazuma Kiyotani, Eisuke Tomiyama, et al.
Oncoimmunology|February 8, 2021
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world dataElizabeth Dudnik, Mor Moskovitz, Yakir Rottenberg, et al.
Oncoimmunology|February 25, 2021
A multicenter characterization of hepatitis associated with immune checkpoint inhibitorsJ Randall Patrinely, Ben McGuigan, Sunandana Chandra, et al.
Oncoimmunology|February 25, 2021
Anti-Ly6G binding and trafficking mediate positive neutrophil selection to unleash the anti-tumor efficacy of radiation therapyGaël Boivin, Pierre-Benoit Ancey, Romain Vuillefroy de Silly, et al.
Pageof 379